WINDWARD BIO GROUP AG (WWB)
Operates as a holding company whose subsidiaries develops and commercializes therapeutics
Sector: Biological Products, (No Diagnostic Substances)
Industry: Medical - Pharmaceuticals
Windward Bio Group AG
NASDAQ:WWBHealthcare · Medical - Pharmaceuticals
+5.40%$30.04
CLOSED · Nov 16Prev close$28.50+5.40%Close$30.040.00%AH close$30.04
AH$30.04+0.00%vs close
Mkt Cap$1.74B
EV-
Float10.29M
O/S58.04M
VOL238K sh
$ Vol$6.29M
RVOL0.31×
Inst Own-
Net Cash/Sh-
Dilution
MCap$1.74BFloat10.29MO/S58.04M
Dilution
Pipeline2 lead-sponsored trials·2 active0 completed
Trials need funding. See this company's dilution risk and cash position.
Clinical Trials
- Phase 2Recruiting
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
WIN378, Placebo
Asthma
NCT07120503Enrollment600StartJul 2025Primary CompletionOct 2028est.CompletionNov 2028est. - Phase 2Recruiting
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
WIN378, Placebo
COPD (Chronic Obstructive Pulmonary Disease)
NCT07646587Enrollment105StartJun 2026Primary CompletionDec 2027est.CompletionJan 2028est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Phase 2 | Recruiting | WIN378, Placebo | NCT07120503 |
| Phase 2 | Recruiting | WIN378, Placebo | NCT07646587 |